glp-1 kidney disease news receptor agonists and next-generation metabolic hormone therapies in chronic Real-World Evidence for GLP-1 Receptor
Description
Patients treated with Hepzato saw a 73.6% disease control rate
Oral versions of GLP-1Ra are still under investigation for the treatment of obesity, though they thus far have lower efficacy [25]
Its important to approach treatment with realistic expectations, as results and timelines differ from person to person
Ask about the weight management program first
This is vital, as weight loss can sometimes result in muscle loss if protein intake is low
